The Asthma and Allergy Research Center at Washington University is striving to advance and improve medication use in the areas of asthma, allergy and immunology through clinical research trials.
Our goal is to provide top-notch care to our research participants while providing quality data for our research. We are focused on expanding research by conducting a variety of clinical trials that pertain to asthma, allergy and immunological diseases, particularly hereditary angioedema (HAE).
Our faculty and staff at the research center are experienced and certified and conduct clinical trials using best practices. They have been involved in many clinical trials leading to FDA approval for asthma, allergy and HAE medications.
Participation in clinical trials
We recognize that none of the medications we have today would be possible without the altruistic support of research participants. We value the commitment and sacrifice of our research patients and our first priority is their health and safety. We pre-screen for all studies throughout the year.
Currently we are enrolling for multiple asthma and allergy studies. We are also enrolling and screening for an HAE prophylaxis study. All participants are compensated for their time and travel. Additionally, they will receive free visits with the study doctor, health care assessments, and free study medication.
If you would like to learn more about becoming a research participant at The Asthma and Allergy Research Center, please contact:
Hereditary angioedema (HAE)
If you have hereditary angioedema (HAE) and are interested in learning more about our practice or more about our clinical trials, please contact Tarisa Mantia directly (see contact information above) and follow the Washington University Hereditary Angioedema (HAE) Clinical Studies Facebook Page.